Relay Therapeutics EPS RLAY

Diluted earnings per share by quarter and over the last twelve months, from 2019.

Relay Therapeutics' earnings per share was −$1.57 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.41.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.41	n/a	−$1.57
Q1 FY26	Mar 31, 2026	−$0.41	n/a	−$1.57
Q4 FY25	Dec 31, 2025	−$0.32	n/a	−$1.62
Q3 FY25	Sep 30, 2025	−$0.43	n/a	−$1.75
Q2 FY25	Jun 30, 2025	−$0.41	n/a	−$1.95
Q1 FY25	Mar 31, 2025	−$0.46	n/a	−$2.23
Q4 FY24	Dec 31, 2024	−$0.45	n/a	−$2.39
Q3 FY24	Sep 30, 2024	−$0.63	n/a	−$2.61
Q2 FY24	Jun 30, 2024	−$0.69	n/a	−$2.52
Q1 FY24	Mar 31, 2024	−$0.62	n/a	−$2.64
Q4 FY23	Dec 31, 2023	−$0.67	n/a	−$2.80
Q3 FY23	Sep 30, 2023	−$0.54	n/a	−$2.69

Companies in Biotechnology nearest Relay Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
RLAYRelay Therapeutics	−$1.57
ADMAAdma Biologics	$0.70	−18% a year
VCELVericel	$0.46	+283% a year
KRYSKrystal Biotech	$7.98	+62% a year
RGENRepligen	$0.73
TECHBIO-TECHNE	$1.15	+150% a year
HALOHalozyme Therapeutics	$3.35	−23% a year
NBIXNeurocrine Biosciences	$6.82	+102% a year
EXELExelixis	$3.18	+53% a year
MGTXMeiraGTx	$0.71
INCYIncyte	$7.85	+78% a year
Peer median	$2.17